We have located links that may give you full text access.
Immunization with Toxoplasma gondii aspartic protease 3 increases survival time of infected mice.
Acta Tropica 2017 July
Aspartic proteases in the Toxoplasma gondii, called TgASP1, 2, 3, and 5, play essential roles in the life cycle. In a previous study, we have demonstrated that TgASP1 is an antigen that prolongs survival time of infected mice. As an in-depth study, we have investigated the protective immunity of TgSAP3. A bioinformatic analysis was used to predict the linear B-cell epitopes and potential Th-cell epitopes on TgASP3, the results suggested that it has a large number of excellent epitopes. Mice were inoculated with a recombinant eukaryotic expression vector to evaluate the immune protection against an infection with the virulent RH strain of T. gondii. The enhanced immune response and increased survival time (up to 18days) were observed for vaccinated mice, showing that the TgASP3 antigen can provides partial protection.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app